We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Executive Vice President and Chief Financial Officer, Daniel J. Brennan, recently engaged in a series of stock transactions, according to a recent SEC filing. The transactions come as the company, now ...
In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...
GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results